By James Eastham, MD and Vincent Laudone, MD
Wednesday, August 14, 2013
Active surveillance is the most appropriate management strategy for many men with prostate cancer, but often this option is never mentioned.
In the Lab
By Esther Napolitano, BS, Science Writer/Editor | Friday, August 9, 2013
A Memorial Sloan-Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, August 7, 2013
Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.
By Julie Grisham, MS, Science Writer/Editor | Monday, August 5, 2013
Jorge Reis-Filho studies the genetic alterations that drive the malignant behavior of cells in rare types of breast cancer.
In the News
By Media Staff | Wednesday, July 31, 2013
Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed on PBS NewsHour about a recent recommendation from a National Cancer Institute working group that proposed changing the definition of cancer.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Tuesday, July 30, 2013
A new online decision tool can help current or former smokers determine whether they would benefit from lung cancer screening.
By Christina Pernambuco-Holsten, MA | Monday, July 29, 2013
Bridges, Memorial Sloan-Kettering’s newsletter written by and for cancer survivors, celebrates its fifth year of publication this summer.
By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research | Friday, July 26, 2013
The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.
Ask the Expert
By Jim Stallard, MA, Writer/Editor | Wednesday, July 24, 2013
In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.
By Memorial Sloan-Kettering | Monday, July 22, 2013
Internist and medical oncologist Virginia Klimek discusses the importance of research, clinical trials, and patient education in finding new treatments for myelodysplastic syndromes (MDS).
By Media Staff | Tuesday, July 16, 2013
Memorial Sloan-Kettering is one of the nation’s top two hospitals for cancer care for the 24th year in a row and is also recognized for excellence in a range of medical specialties.
By Julie Grisham, MS, Science Writer/Editor | Monday, July 15, 2013
Memorial Sloan-Kettering’s Brain Tumor Center provides world-class care to people with low-grade glioma, a type of slow-growing brain tumor.
By Esther Napolitano, BS, Science Writer/Editor | Friday, July 12, 2013
Scott Armstrong specializes in the treatment of leukemia in children. His research focuses on the disease in children and adults.
In the News
By Media Staff | Tuesday, July 9, 2013
Medical oncologist Mark G. Kris and one of his patients were interviewed for a CBS This Morning segment that describes how a Memorial Sloan-Kettering team trains the supercomputer IBM Watson to help doctors identify the best cancer management options for individual patients.
Ask the Expert
By Jim Stallard, MA, Writer/Editor | Wednesday, July 3, 2013
In this “Ask the Expert” feature, Cara Anselmo, a registered dietitian nutritionist, discusses the importance of maintaining a healthy diet while undergoing breast cancer treatment.